BTK protein has been shown to be crucial for tumor-promoting function of macrophages in different neoplasias, especially in CLL, where modulation of TAMs has been shown to be also a relevant mode of action of ibrutinib [35, 36]. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.